Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. (Q54232902)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. |
scientific article |
Statements
Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. (English)
Monika Artl
Martin Filipits
Margit Resel
Ricarda Graf
Bettina Weißenbacher
Sigurd Lax
Fritz Wrba
Richard Greil
Otto Dietze
Friedrich Hofbauer
Gerhard Böhm
Gerald Höfler
Hellmut Samonigg
Renate Schaberl-Moser
Marija Balic
Nadia Dandachi
6 December 2013
27
6
906-915
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference